Contineum Therapeutics (CTNM) Change in Acquisitions & Divestments (2023 - 2025)

Contineum Therapeutics has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $37.3 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $37.3 million for Q4 2025, down 17.3% from a year ago — trailing twelve months through Dec 2025 was $159.0 million (up 1.18% YoY), and the annual figure for FY2025 was $159.0 million, up 1.18%.
  • Change in Acquisitions & Divestments for Q4 2025 was $37.3 million at Contineum Therapeutics, up from $33.7 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CTNM hit a ceiling of $48.7 million in Q1 2025 and a floor of $12.6 million in Q3 2023.
  • Median Change in Acquisitions & Divestments over the past 3 years was $35.5 million (2025), compared with a mean of $32.7 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 235.53% in 2024 and later fell 20.35% in 2025.
  • Contineum Therapeutics' Change in Acquisitions & Divestments stood at $31.3 million in 2023, then surged by 44.03% to $45.1 million in 2024, then dropped by 17.3% to $37.3 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $37.3 million (Q4 2025), $33.7 million (Q3 2025), and $39.4 million (Q2 2025) per Business Quant data.